Sepsis in an aging population

Critical Care Medicine

Volumn 34, Issue 1, 2006, Pages 234-235

  Paz, Harold L ^a   Martin, Andrew A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Critical illness; Epidemiology; Gerontology; Intensive care; Sepsis

Indexed keywords

AGING; CAUSE OF DEATH; EDITORIAL; EPIDEMIOLOGICAL DATA; GROUPS BY AGE; HOSPITALIZATION; HUMAN; IMMUNOPATHOLOGY; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INTENSIVE CARE UNIT; LENGTH OF STAY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS;

EID: 29744450714     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000196085.41653.9C     Document Type: Editorial

References (12)

1. Arias E, Anderson R, Kung H, et al: Deaths: Final data for 2001. Nat'l Vital Stat Rep 2003; 52:1-115
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
3. Guidet B, Aegerter P, Gauzit R, et al., on behalf of the CUBRSG: Incidence and impact of organ dysfunctions associated with sepsis. Chest. 2005; 127:942-951
4. U.S. Census Bureau PD, Branch PP. 2004
5. Martin GS, Mannino DM, Moss M: The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006; 34:15-21
6. Sands KE, Bates DW, Lanken PN, et al: Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 1997; 278:234-240
7. Angus D, Barnato A, Linde-Zwirble W, et al: Use of intensive care at the end of life in the United States: An epidemiologic study. Critical Care Medicine 2004; 32:638-643
8. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
9. Wheeler AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med 1999; 340:207-214
10. Bernard GR, Vincent J-L, Laterre P-F, et al: Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med. 2001; 344:699-709
11. Manns BJ, Lee H, Doig CJ, et al: An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 2002; 347:993-1000
12. Levy MM, Pronovost PJ, Dellinger RP, et al: Sepsis change bundles: Converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 2004; 32:S595-S597